Semin Reprod Med 2024; 42(03): 178-192
DOI: 10.1055/s-0044-1795160
Review Article

A Review of Autoimmune Thyroid Diseases and Their Complex Interplay with Female Fertility

1   Department of Medicine, University of Rochester School of Medicine & Dentistry, Rochester, New York
,
2   Department of Obstetrics & Gynecology, University of Rochester Medical Center, Rochester, New York
,
1   Department of Medicine, University of Rochester School of Medicine & Dentistry, Rochester, New York
› Author Affiliations

Abstract

Hashimoto thyroiditis and Graves' disease are autoimmune thyroid disorders that are common in women of reproductive age and have a complex relationship with female fertility and health of the maternal–fetal dyad. Both hyperthyroidism and hypothyroidism, whether subclinical or overt in severity, directly or indirectly affect nearly every level of the hypothalamic–pituitary–ovary axis, uterine and ovarian function, as well as fetal development from implantation through delivery. Autoimmunity itself also appears to negatively impact both spontaneous and assisted fertility, as well as miscarriage risk, although the mechanism remains unclear, and the presence and magnitude of risk is variable in published literature. While treatment of overt hyperthyroidism and hypothyroidism is unequivocally recommended by professional societies, the impact of treatment on fertility outcomes, and the role of treatment in subclinical thyroid disease is more controversial. Unfortunately, levothyroxine has not been shown to abrogate the risk of subfertility and miscarriage observed in euthyroid thyroid autoantibody positive women.

* Co-first authors.




Publication History

Article published online:
12 December 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev 2015; 14 (02) 174-180
  • 2 Vanderpump MP, Tunbridge WM, French JM. et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995; 43 (01) 55-68
  • 3 McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine 2012; 42 (02) 252-265
  • 4 Silva JF, Ocarino NM, Serakides R. Thyroid hormones and female reproduction. Biol Reprod 2018; 99 (05) 907-921
  • 5 Lee SY, Pearce EN. Assessment and treatment of thyroid disorders in pregnancy and the postpartum period. Nat Rev Endocrinol 2022; 18 (03) 158-171
  • 6 Concepción-Zavaleta MJ, Coronado-Arroyo JC, Quiroz-Aldave JE, Concepción-Urteaga LA, Paz-Ibarra J. Thyroid dysfunction and female infertility. A comprehensive review. Diabetes Metab Syndr 2023; 17 (11) 102876
  • 7 Chaker L, Razvi S, Bensenor IM, Azizi F, Pearce EN, Peeters RP. Hypothyroidism. Nat Rev Dis Primers 2022; 8 (01) 30
  • 8 Davies TF, Andersen S, Latif R. et al. Graves' disease. Nat Rev Dis Primers 2020; 6 (01) 52
  • 9 Tomer Y. Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid 2010; 20 (07) 715-725
  • 10 Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril 2020; 113 (03) 533-535
  • 11 Cox CM, Thoma ME, Tchangalova N. et al. Infertility prevalence and the methods of estimation from 1990 to 2021: a systematic review and meta-analysis. Hum Reprod Open 2022; 2022 (04) hoac051
  • 12 Macaluso M, Wright-Schnapp TJ, Chandra A. et al. A public health focus on infertility prevention, detection, and management. Fertil Steril 2010; 93 (01) 16.e1-16.e10
  • 13 Munro MG, Balen AH, Cho S. et al; FIGO Committee on Menstrual Disorders and Related Health Impacts, and FIGO Committee on Reproductive Medicine, Endocrinology, and Infertility. The FIGO Ovulatory Disorders Classification System†. Hum Reprod 2022; 37 (10) 2446-2464
  • 14 Tańska K, Gietka-Czernel M, Glinicki P, Kozakowski J. Thyroid autoimmunity and its negative impact on female fertility and maternal pregnancy outcomes. Front Endocrinol (Lausanne) 2023; 13: 1049665
  • 15 Moledina M, Damato EM, Lee V. The changing landscape of thyroid eye disease: current clinical advances and future outlook. Eye (Lond) 2024; 38 (08) 1425-1437
  • 16 Valencia-Sanchez C, Pittock S, Dubey D. et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis: clinical presentation and misdiagnosis (1900). Neurology 2020; 94 (15, Suppl) 1900
  • 17 Chen AX, Leung AM, Korevaar TIM. Thyroid function and conception. N Engl J Med 2019; 381 (02) 178-181
  • 18 Brix TH, Kyvik KO, Hegedüs L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab 2000; 85 (02) 536-539
  • 19 Brix TH, Christensen K, Holm NV, Harvald B, Hegedüs L. A population-based study of Graves' disease in Danish twins. Clin Endocrinol (Oxf) 1998; 48 (04) 397-400
  • 20 Tomer Y, Ban Y, Concepcion E. et al. Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 2003; 73 (04) 736-747
  • 21 Lee HJ, Li CW, Hammerstad SS, Stefan M, Tomer Y. Immunogenetics of autoimmune thyroid diseases: a comprehensive review. J Autoimmun 2015; 64: 82-90
  • 22 Husebye ES, Anderson MS, Kämpe O. Autoimmune polyendocrine syndromes. N Engl J Med 2018; 378 (12) 1132-1141
  • 23 Weider T, Richardson SJ, Morgan NG, Paulsen TH, Dahl-Jørgensen K, Hammerstad SS. Upregulation of HLA Class I and antiviral tissue responses in Hashimoto's Thyroiditis. Thyroid 2020; 30 (03) 432-442
  • 24 Menconi F, Hasham A, Tomer Y. Environmental triggers of thyroiditis: hepatitis C and interferon-α. J Endocrinol Invest 2011; 34 (01) 78-84
  • 25 Matos-Santos A, Nobre EL, Costa JG. et al. Relationship between the number and impact of stressful life events and the onset of Graves' disease and toxic nodular goitre. Clin Endocrinol (Oxf) 2001; 55 (01) 15-19
  • 26 Stan MN, Bahn RS. Risk factors for development or deterioration of Graves' ophthalmopathy. Thyroid 2010; 20 (07) 777-783
  • 27 Muller AF, Drexhage HA, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev 2001; 22 (05) 605-630
  • 28 Croce L, Di Dalmazi G, Orsolini F. et al. Graves' disease and the post-partum period: an intriguing relationship. Front Endocrinol (Lausanne) 2019; 10: 853
  • 29 Burch HB. Drug effects on the thyroid. N Engl J Med 2019; 381 (08) 749-761
  • 30 Shi TT, Xin Z, Hua L. et al. Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study. J Endocrinol Invest 2019; 42 (08) 967-978
  • 31 Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol 2015; 3 (04) 286-295
  • 32 Khoury EL, Pereira L, Greenspan FS. Induction of HLA-DR expression on thyroid follicular cells by cytomegalovirus infection in vitro. Evidence for a dual mechanism of induction. Am J Pathol 1991; 138 (05) 1209-1223
  • 33 Davies TF, Piccinini LA. Intrathyroidal MHC class II antigen expression and thyroid autoimmunity. Endocrinol Metab Clin North Am 1987; 16 (02) 247-268
  • 34 Misaki T, Takeuchi R, Miyamoto S, Hirano A, Kasagi K, Konishi J. Induction in vitro of 72-kD heat shock protein in a continuous culture of rat thyroid cells, FRTL5. Clin Exp Immunol 1994; 98 (02) 234-239
  • 35 Benvenga S, Guarneri F. Molecular mimicry and autoimmune thyroid disease. Rev Endocr Metab Disord 2016; 17 (04) 485-498
  • 36 Brown EDL, Obeng-Gyasi B, Hall JE, Shekhar S. The thyroid hormone axis and female reproduction. Int J Mol Sci 2023; 24 (12) 9815
  • 37 Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev 2001; 81 (03) 1097-1142
  • 38 Rousset B, Dupuy C, Miot F, Dumont J. Chapter 2 thyroid hormone synthesis and secretion. In: Feingold KR, Anawalt B, Blackman MR. et al, eds. Endotext. MDText.com, Inc.; 2000
  • 39 Luongo C, Dentice M, Salvatore D. Deiodinases and their intricate role in thyroid hormone homeostasis. Nat Rev Endocrinol 2019; 15 (08) 479-488
  • 40 Furlow JD, Neff ES. A developmental switch induced by thyroid hormone: Xenopus laevis metamorphosis. Trends Endocrinol Metab 2006; 17 (02) 40-47
  • 41 Larsen PR. Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones. N Engl J Med 1982; 306 (01) 23-32
  • 42 Nillni EA. Regulation of the hypothalamic thyrotropin releasing hormone (TRH) neuron by neuronal and peripheral inputs. Front Neuroendocrinol 2010; 31 (02) 134-156
  • 43 Mattheij JA, Swarts JJ, Lokerse P, van Kampen JT, Van der Heide D. Effect of hypothyroidism on the pituitary-gonadal axis in the adult female rat. J Endocrinol 1995; 146 (01) 87-94
  • 44 Grattan DR, Szawka RE. Kisspeptin and prolactin. Semin Reprod Med 2019; 37 (02) 93-104
  • 45 Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010; 31 (05) 702-755
  • 46 Anasti JN, Flack MR, Froehlich J, Nelson LM, Nisula BC. A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metab 1995; 80 (01) 276-279
  • 47 Kabodmehri R, Sharami SH, Sorouri ZZ. et al. The relationship between thyroid function and ovarian reserve: a prospective cross-sectional study. Thyroid Res 2021; 14 (01) 22
  • 48 Fan H, Ren Q, Sheng Z, Deng G, Li L. The role of the thyroid in polycystic ovary syndrome. Front Endocrinol (Lausanne) 2023; 14: 1242050
  • 49 Sun SC, Hsu PJ, Wu FJ, Li SH, Lu CH, Luo CW. Thyrostimulin, but not thyroid-stimulating hormone (TSH), acts as a paracrine regulator to activate the TSH receptor in mammalian ovary. J Biol Chem 2010; 285 (06) 3758-3765
  • 50 Meng L, Rijntjes E, Swarts HJ, Keijer J, Teerds KJ. Prolonged hypothyroidism severely reduces ovarian follicular reserve in adult rats. J Ovarian Res 2017; 10 (01) 19
  • 51 Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med 2001; 344 (23) 1743-1749
  • 52 Selva DM, Hammond GL. Thyroid hormones act indirectly to increase sex hormone-binding globulin production by liver via hepatocyte nuclear factor-4alpha. J Mol Endocrinol 2009; 43 (01) 19-27
  • 53 Gardner RM, Kirkland JL, Ireland JS, Stancel GM. Regulation of the uterine response to estrogen by thyroid hormone. Endocrinology 1978; 103 (04) 1164-1172
  • 54 Aghajanova L, Stavreus-Evers A, Lindeberg M, Landgren BM, Sparre LS, Hovatta O. Thyroid-stimulating hormone receptor and thyroid hormone receptors are involved in human endometrial physiology. Fertil Steril 2011; 95 (01) 230-237 , 237.e1–237.e2
  • 55 Rodríguez-Castelán J, Del Moral-Morales A, Piña-Medina AG. et al. Hypothyroidism induces uterine hyperplasia and inflammation related to sex hormone receptors expression in virgin rabbits. Life Sci 2019; 230: 111-120
  • 56 Inuwa IM, Williams MA. A morphometric study on the endometrium of rat uterus in hypothyroid and thyroxine treated hypothyroid rats. Ups J Med Sci 2006; 111 (02) 215-225
  • 57 Reynolds LP, Borowicz PP, Caton JS. et al. Uteroplacental vascular development and placental function: an update. Int J Dev Biol 2010; 54 (2-3): 355-366
  • 58 Ren SG, Seliktar J, Li X, Hershman JM, Braunstein GD, Melmed S. In vivo and in vitro regulation of thyroid leukemia inhibitory factor (LIF): marker of hypothyroidism. J Clin Endocrinol Metab 1999; 84 (08) 2883-2887
  • 59 Souza CA, Silva JF, Silva CL, Ocarino NM, Serakides R. Thyroid hormones affect decidualization and angiogenesis in the decidua and metrial gland of rats. Pesqui Vet Bras 2017; 37: 1002-1014
  • 60 Deng WB, Liang XH, Liu JL, Yang ZM. Regulation and function of deiodinases during decidualization in female mice. Endocrinology 2014; 155 (07) 2704-2717
  • 61 Colicchia M, Campagnolo L, Baldini E, Ulisse S, Valensise H, Moretti C. Molecular basis of thyrotropin and thyroid hormone action during implantation and early development. Hum Reprod Update 2014; 20 (06) 884-904
  • 62 Silva JF, Vidigal PN, Galvão DD. et al. Fetal growth restriction in hypothyroidism is associated with changes in proliferative activity, apoptosis and vascularisation of the placenta. Reprod Fertil Dev 2012; 24 (07) 923-931
  • 63 Silva JF, Ocarino NM, Serakides R. Placental angiogenic and hormonal factors are affected by thyroid hormones in rats. Pathol Res Pract 2015; 211 (03) 226-234
  • 64 Silva JF, Ocarino NM, Serakides R. Maternal thyroid dysfunction affects placental profile of inflammatory mediators and the intrauterine trophoblast migration kinetics. Reproduction 2014; 147 (06) 803-816
  • 65 Bucci I, Giuliani C, Di Dalmazi G, Formoso G, Napolitano G. Thyroid autoimmunity in female infertility and assisted reproductive technology outcome. Front Endocrinol (Lausanne) 2022; 13: 768363
  • 66 Alexander EK, Pearce EN, Brent GA. et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 2017; 27 (03) 315-389
  • 67 Artini PG, Uccelli A, Papini F. et al. Infertility and pregnancy loss in euthyroid women with thyroid autoimmunity. Gynecol Endocrinol 2013; 29 (01) 36-41
  • 68 Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160 (04) 526-534
  • 69 Hollowell JG, Staehling NW, Flanders WD. et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87 (02) 489-499
  • 70 Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet 2017; 390 (10101): 1550-1562
  • 71 Spencer CA. Laboratory thyroid tests: a historical perspective. Thyroid 2023; 33 (04) 407-419
  • 72 Gupta AK, Kumar S. Utility of antibodies in the diagnoses of thyroid diseases: a review article. Cureus 2022; 14 (11) e31233
  • 73 Yuen HY, Wong KT, Ahuja AT. Sonography of diffuse thyroid disease. Australas J Ultrasound Med 2016; 19 (01) 13-29
  • 74 Osinga JAJ, Derakhshan A, Palomaki GE. et al. TSH and FT4 reference intervals in pregnancy: a systematic review and individual participant data meta-analysis. J Clin Endocrinol Metab 2022; 107 (10) 2925-2933
  • 75 Korevaar TIM, Medici M, Visser TJ, Peeters RP. Thyroid disease in pregnancy: new insights in diagnosis and clinical management. Nat Rev Endocrinol 2017; 13 (10) 610-622
  • 76 Dong AC, Stagnaro-Green A. Differences in diagnostic criteria mask the true prevalence of thyroid disease in pregnancy: a systematic review and meta-analysis. Thyroid 2019; 29 (02) 278-289
  • 77 Maraka S, Singh Ospina NM, Mastorakos G, O'Keeffe DT. Subclinical hypothyroidism in women planning conception and during pregnancy: Who should be treated and how?. J Endocr Soc 2018; 2 (06) 533-546
  • 78 Yoshioka W, Amino N, Ide A. et al. Thyroxine treatment may be useful for subclinical hypothyroidism in patients with female infertility. Endocr J 2015; 62 (01) 87-92
  • 79 Moolhuijsen LME, Visser JA. Anti-Müllerian hormone and ovarian reserve: update on assessing ovarian function. J Clin Endocrinol Metab 2020; 105 (11) 3361-3373
  • 80 Hasegawa Y, Kitahara Y, Osuka S, Tsukui Y, Kobayashi M, Iwase A. Effect of hypothyroidism and thyroid autoimmunity on the ovarian reserve: a systematic review and meta-analysis. Reprod Med Biol 2021; 21 (01) e12427
  • 81 Kucukler FK, Gorkem U, Simsek Y, Kocabas R, Guler S. Evaluation of ovarian reserve in women with overt or subclinical hypothyroidism. Arch Med Sci 2018; 14 (03) 521-526
  • 82 Rao M, Wang H, Zhao S. et al. Subclinical hypothyroidism is associated with lower ovarian reserve in women aged 35 years or older. Thyroid 2020; 30 (01) 95-105
  • 83 Orouji Jokar T, Fourman LT, Lee H, Mentzinger K, Fazeli PK. Higher TSH levels within the normal range are associated with unexplained infertility. J Clin Endocrinol Metab 2018; 103 (02) 632-639
  • 84 Hiraoka T, Wada-Hiraike O, Hirota Y. et al. The impact of elevated thyroid stimulating hormone on female subfertility. Reprod Med Biol 2015; 15 (02) 121-126
  • 85 Birjandi B, Ramezani Tehrani F, Amouzegar A, Tohidi M, Bidhendi Yarandi R, Azizi F. The association between subclinical hypothyroidism and TPOAb positivity with infertility in a population-based study: Tehran thyroid study (TTS). BMC Endocr Disord 2021; 21 (01) 108
  • 86 Cramer DW, Sluss PM, Powers RD. et al. Serum prolactin and TSH in an in vitro fertilization population: is there a link between fertilization and thyroid function?. J Assist Reprod Genet 2003; 20 (06) 210-215
  • 87 Fumarola A, Grani G, Romanzi D. et al. Thyroid function in infertile patients undergoing assisted reproduction. Am J Reprod Immunol 2013; 70 (04) 336-341
  • 88 Abdel Rahman AH, Aly Abbassy H, Abbassy AA. Improved in vitro fertilization outcomes after treatment of subclinical hypothyroidism in infertile women. Endocr Pract 2010; 16 (05) 792-797
  • 89 Kim CH, Ahn JW, Kang SP, Kim SH, Chae HD, Kang BM. Effect of levothyroxine treatment on in vitro fertilization and pregnancy outcome in infertile women with subclinical hypothyroidism undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril 2011; 95 (05) 1650-1654
  • 90 Chai J, Yeung WY, Lee CY, Li HW, Ho PC, Ng HY. Live birth rates following in vitro fertilization in women with thyroid autoimmunity and/or subclinical hypothyroidism. Clin Endocrinol (Oxf) 2014; 80 (01) 122-127
  • 91 Chan S, Boelaert K. Optimal management of hypothyroidism, hypothyroxinaemia and euthyroid TPO antibody positivity preconception and in pregnancy. Clin Endocrinol (Oxf) 2015; 82 (03) 313-326
  • 92 Davis LE, Leveno KJ, Cunningham FG. Hypothyroidism complicating pregnancy. Obstet Gynecol 1988; 72 (01) 108-112
  • 93 Leung AS, Millar LK, Koonings PP, Montoro M, Mestman JH. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 1993; 81 (03) 349-353
  • 94 Männistö T, Mendola P, Grewal J, Xie Y, Chen Z, Laughon SK. Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort. J Clin Endocrinol Metab 2013; 98 (07) 2725-2733
  • 95 Maraka S, Ospina NM, O'Keeffe DT. et al. Subclinical hypothyroidism in pregnancy: a systematic review and meta-analysis. Thyroid 2016; 26 (04) 580-590
  • 96 Allan WC, Haddow JE, Palomaki GE. et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen 2000; 7 (03) 127-130
  • 97 Taylor PN, Minassian C, Rehman A. et al. TSH levels and risk of miscarriage in women on long-term levothyroxine: a community-based study. J Clin Endocrinol Metab 2014; 99 (10) 3895-3902
  • 98 Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 2002; 12 (01) 63-68
  • 99 Baloch Z, Carayon P, Conte-Devolx B. et al; Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003; 13 (01) 3-126
  • 100 van den Boogaard E, Vissenberg R, Land JA. et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update 2011; 17 (05) 605-619
  • 101 Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 2005; 90 (09) 5483-5488
  • 102 Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab 2010; 95 (09) E44-E48
  • 103 Seungdamrong A, Steiner AZ, Gracia CR. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Reproductive Medicine Network. Preconceptional antithyroid peroxidase antibodies, but not thyroid-stimulating hormone, are associated with decreased live birth rates in infertile women. Fertil Steril 2017; S0015-0282 (17)31748-X
  • 104 Liu H, Shan Z, Li C. et al. Maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage: a prospective cohort study. Thyroid 2014; 24 (11) 1642-1649
  • 105 Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org. Subclinical hypothyroidism in the infertile female population: a guideline. Fertil Steril 2024; 121 (05) 765-782
  • 106 Waise A, Price HC. The upper limit of the reference range for thyroid-stimulating hormone should not be confused with a cut-off to define subclinical hypothyroidism. Ann Clin Biochem 2009; 46 (Pt 2): 93-98
  • 107 Kim JJ, Yoon JW, Kim MJ, Kim SM, Hwang KR, Choi YM. Thyroid autoimmunity markers in women with polycystic ovary syndrome and controls. Hum Fertil (Camb) 2022; 25 (01) 128-134
  • 108 Kamrul-Hasan A, Aalpona FTZ, Mustari M. et al. Prevalence of thyroid dysfunction and thyroid autoimmunity in polycystic ovary syndrome: a multicenter study from Bangladesh. Thyroid Research and Practice 2020; 17 (02) 76-81
  • 109 Romitti M, Fabris VC, Ziegelmann PK, Maia AL, Spritzer PM. Association between PCOS and autoimmune thyroid disease: a systematic review and meta-analysis. Endocr Connect 2018; 7 (11) 1158-1167
  • 110 Poppe K, Glinoer D, Van Steirteghem A. et al. Thyroid dysfunction and autoimmunity in infertile women. Thyroid 2002; 12 (11) 997-1001
  • 111 Petta CA, Arruda MS, Zantut-Wittmann DE, Benetti-Pinto CL. Thyroid autoimmunity and thyroid dysfunction in women with endometriosis. Hum Reprod 2007; 22 (10) 2693-2697
  • 112 Poppe K, Bisschop P, Fugazzola L, Minziori G, Unuane D, Weghofer A. 2021 European Thyroid Association Guideline on Thyroid Disorders prior to and during Assisted Reproduction. Eur Thyroid J 2021; 9 (06) 281-295
  • 113 Korevaar TI, Steegers EA, Pop VJ. et al. Thyroid autoimmunity impairs the thyroidal response to human chorionic gonadotropin: two population-based prospective cohort studies. J Clin Endocrinol Metab 2017; 102 (01) 69-77
  • 114 Venables A, Wong W, Way M, Homer HA. Thyroid autoimmunity and IVF/ICSI outcomes in euthyroid women: a systematic review and meta-analysis. Reprod Biol Endocrinol 2020; 18 (01) 120
  • 115 Tan S, Dieterle S, Pechlavanis S, Janssen OE, Fuhrer D. Thyroid autoantibodies per se do not impair intracytoplasmic sperm injection outcome in euthyroid healthy women. Eur J Endocrinol 2014; 170 (04) 495-500
  • 116 Unuane D, Velkeniers B. Impact of thyroid disease on fertility and assisted conception. Best Pract Res Clin Endocrinol Metab 2020; 34 (04) 101378
  • 117 Unuane D, Velkeniers B, Bravenboer B. et al. Impact of thyroid autoimmunity in euthyroid women on live birth rate after IUI. Hum Reprod 2017; 32 (04) 915-922
  • 118 Kaprara A, Krassas GE. Thyroid autoimmunity and miscarriage. Hormones (Athens) 2008; 7 (04) 294-302
  • 119 Lin C, Xiang Y, Li J. The contribution of thyroid autoimmunity to miscarriage in euthyroid women. Minerva Med 2016; 107 (03) 173-181
  • 120 Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarasamy A. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ 2011; 342: d2616
  • 121 Medenica S, Garalejic E, Arsic B. et al. Follicular fluid thyroid autoantibodies, thyrotropin, free thyroxine levels and assisted reproductive technology outcome. PLoS One 2018; 13 (10) e0206652
  • 122 Monteleone P, Parrini D, Faviana P. et al. Female infertility related to thyroid autoimmunity: the ovarian follicle hypothesis. Am J Reprod Immunol 2011; 66 (02) 108-114
  • 123 Rahnama R, Mahmoudi AR, Kazemnejad S. et al. Thyroid peroxidase in human endometrium and placenta: a potential target for anti-TPO antibodies. Clin Exp Med 2021; 21 (01) 79-88
  • 124 Jonklaas J, Bianco AC, Bauer AJ. et al; American Thyroid Association Task Force on Thyroid Hormone Replacement. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on thyroid hormone replacement. Thyroid 2014; 24 (12) 1670-1751
  • 125 Practice Committee of the American Society for Reproductive Medicine. Subclinical hypothyroidism in the infertile female population: a guideline. Fertil Steril 2015; 104 (03) 545-553
  • 126 Dhillon-Smith RK, Middleton LJ, Sunner KK. et al. Levothyroxine in women with thyroid peroxidase antibodies before conception. N Engl J Med 2019; 380 (14) 1316-1325
  • 127 van Dijk MM, Vissenberg R, Fliers E. et al. Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol 2022; 10 (05) 322-329
  • 128 Wang H, Gao H, Chi H. et al. Effect of levothyroxine on miscarriage among women with normal thyroid function and thyroid autoimmunity undergoing in vitro fertilization and embryo transfer: a randomized clinical trial. JAMA 2017; 318 (22) 2190-2198
  • 129 Schomburg L. Selenium, selenoproteins and the thyroid gland: interactions in health and disease. Nat Rev Endocrinol 2011; 8 (03) 160-171
  • 130 Mantovani G, Isidori AM, Moretti C. et al. Selenium supplementation in the management of thyroid autoimmunity during pregnancy: results of the “SERENA study”, a randomized, double-blind, placebo-controlled trial. Endocrine 2019; 66 (03) 542-550
  • 131 Negro R, Greco G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 2007; 92 (04) 1263-1268
  • 132 Mao J, Pop VJ, Bath SC, Vader HL, Redman CW, Rayman MP. Effect of low-dose selenium on thyroid autoimmunity and thyroid function in UK pregnant women with mild-to-moderate iodine deficiency. Eur J Nutr 2016; 55 (01) 55-61
  • 133 Hubalewska-Dydejczyk A, Duntas L, Gilis-Januszewska A. Pregnancy, thyroid, and the potential use of selenium. Hormones (Athens) 2020; 19 (01) 47-53
  • 134 Zhou P, Yao Q, Zhao Q. et al. IVF/ICSI outcomes of euthyroid infertile women with thyroid autoimmunity: does treatment with aspirin plus prednisone matter?. BMC Pregnancy Childbirth 2022; 22 (01) 263
  • 135 Kiprov DD, Nachtigall RD, Weaver RC, Jacobson A, Main EK, Garovoy MR. The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities. Am J Reprod Immunol 1996; 36 (04) 228-234
  • 136 Stricker RB, Steinleitner A, Bookoff CN, Weckstein LN, Winger EE. Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin. Fertil Steril 2000; 73 (03) 536-540
  • 137 Bozic Antic I, Macut D, Popovic B. et al. Recurrent spontaneous abortions, Hashimoto thyroiditis and alopecia totalis: response to anticoagulation and intravenous immunoglobulin therapy. Gynecol Endocrinol 2014; 30 (02) 100-102
  • 138 Taylor PN, Albrecht D, Scholz A. et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol 2018; 14 (05) 301-316
  • 139 Antonelli A, Fallahi P, Elia G. et al. Graves' disease: clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. Best Pract Res Clin Endocrinol Metab 2020; 34 (01) 101388
  • 140 Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am 1993; 22 (02) 263-277
  • 141 Biondi B, Cooper DS. Subclinical hyperthyroidism. N Engl J Med 2018; 378 (25) 2411-2419
  • 142 Takamatsu J, Sugawara M, Kuma K. et al. Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease. Ann Intern Med 1984; 100 (03) 372-375
  • 143 Diana T, Wüster C, Olivo PD. et al. Performance and specificity of 6 immunoassays for TSH receptor antibodies: a multicenter study. Eur Thyroid J 2017; 6 (05) 243-249
  • 144 Quintino-Moro A, Zantut-Wittmann DE, Tambascia M, Machado HdaC, Fernandes A. High prevalence of infertility among women with Graves' disease and Hashimoto's thyroiditis. Int J Endocrinol 2014; 2014: 982705
  • 145 Joshi JV, Bhandarkar SD, Chadha M, Balaiah D, Shah R. Menstrual irregularities and lactation failure may precede thyroid dysfunction or goitre. J Postgrad Med 1993; 39 (03) 137-141
  • 146 Koutras DA. Disturbances of menstruation in thyroid disease. Ann N Y Acad Sci 1997; 816: 280-284
  • 147 Benson RC, Dailey ME. The menstrual pattern in hyperthyroidism and subsequent posttherapy hypothyroidism. Surg Gynecol Obstet 1955; 100 (01) 19-26
  • 148 Goldsmith RE, Sturgis SH, Lerman J, Stanbury JB. The menstrual pattern in thyroid disease. J Clin Endocrinol Metab 1952; 12 (07) 846-855
  • 149 Andersen SL, Olsen J, Wu CS, Laurberg P. Spontaneous abortion, stillbirth and hyperthyroidism: a Danish population-based study. Eur Thyroid J 2014; 3 (03) 164-172
  • 150 Anselmo J, Cao D, Karrison T, Weiss RE, Refetoff S. Fetal loss associated with excess thyroid hormone exposure. JAMA 2004; 292 (06) 691-695
  • 151 Li Y, Xu T, Mo Q, Fu W, Yao C. Thyrotropin receptor antibody: a novel risk indicator for pregnancy loss. Clin Biochem 2019; 64: 44-48
  • 152 Burch HB, Cooper DS. Management of Graves disease: a review. JAMA 2015; 314 (23) 2544-2554
  • 153 Ross DS, Burch HB, Cooper DS. et al. 2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 2016; 26 (10) 1343-1421
  • 154 Davis LE, Lucas MJ, Hankins GD, Roark ML, Cunningham FG. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 1989; 160 (01) 63-70
  • 155 Andersen SL, Olsen J, Wu CS, Laurberg P. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. J Clin Endocrinol Metab 2013; 98 (11) 4373-4381
  • 156 Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, Tørring O. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol 2008; 158 (01) 69-75